GENE ONLINE|News &
Opinion
Blog

2018-05-01|

May 1, 2004: Broad Institute, the Top Biomedical and Genomic Research Center, Was Officially Launched

by GeneOnline
Share To

On May 1, 2004, the Eli and Edythe L. Broad Institute of MIT and Harvard the Broad Institute, often referred to as the Broad Institute, was formally launched with the funfing from the Eli and Edythe Broad and co-organized by Harvard University and the Massachusetts Institute of Technology. The Broad Institute encourages cooperative research, and has no upper limit to the scale of the budget. The purpose is to integrate knowledge and develop a brand new research cooperation model, to advance genomics medicine. The Broad Institute has became a leading academic institution for genetic and biomedical research. In recent years, one of the most popular CRISPR research has budded from this center.

Reference
https://www.broadinstitute.org/history-leadership/history/history

Image Source
https://www.nytimes.com/2012/01/03/science/broad-institute-director-finds-power-in-numbers.html?_r=0

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Saudi Arabia Reveals Grand Ambition to Become a Global Biotech Powerhouse by 2040
2024-01-26
R&D
Unveiling the Genetic Links to Dietary Preferences: A Milestone in Precision Nutrition
2023-07-26
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
EVENT
Scroll to Top